The global gastric button market, valued at USD 400.44 million in 2022, is expected to grow at a CAGR of 7.5% during the forecast period, with growth increasingly driven by segment-wise performance across product types, end-user applications, and technological platforms. The market can be segmented by product type into balloon-retained G-buttons, bumper-retained G-buttons, and low-profile gastrostomy devices, with low-profile, balloon-retained models representing the largest and fastest-growing segment due to their enhanced patient comfort, reduced visibility under clothing, and lower risk of accidental dislodgement. These devices are particularly favored in pediatric and ambulatory care settings, where mobility and cosmetic discretion are critical. Bumper-retained models remain in use in acute care and short-term applications due to their simplicity and cost-effectiveness.
By end-user, hospitals account for over 50% of total demand, driven by the need for initial placement, post-operative monitoring, and management of acute gastrointestinal conditions. Application-specific growth is evident in home healthcare, where the shift toward decentralized care and aging-in-place is accelerating demand for durable, easy-to-manage G-buttons that support long-term nutritional therapy. The pediatric and geriatric care sectors are another high-growth area, with demand rising for infection-resistant, anti-reflux, and MRI-compatible devices in children with congenital disorders and elderly patients with neurodegenerative diseases. Segment-specific pricing reflects performance tiers, with basic bumper-retained tubes priced between USD 20–50 per unit, while advanced low-profile, anti-migration models with antimicrobial coatings can exceed USD 150 per unit due to R&D intensity and quality assurance requirements.
Product differentiation is emerging through material innovation, fixation technology, and integration with digital health platforms. Leading manufacturers are investing in silicone-elastomer blends, dual-balloon designs, and anti-reflux valves to improve device longevity and reduce complications such as leakage and peristomal infection. Additionally, the integration of QR codes for lot traceability, patient education apps, and telehealth connectivity is enhancing user engagement and adherence.
Read More @ https://www.polarismarketresearch.com/industry-analysis/gastric-button-market
Value chain optimization is a strategic imperative, as healthcare providers seek to reduce hospital readmissions, improve patient outcomes, and meet rising demand for auditable, ESG-compliant medical devices. Leading players are investing in automated manufacturing, in-house testing laboratories, and digital product documentation to ensure compliance with ISO 13485 and IEC 60601 standards. Furthermore, the convergence of gastric buttons with remote monitoring, predictive analytics, and AI-driven nutritional planning is creating new opportunities for application-specific growth, particularly in integrated home care and chronic disease management systems. As the industry evolves beyond utility toward holistic patient wellness, segment-wise performance will increasingly depend on innovation, interoperability, and alignment with evolving healthcare delivery models.
Competitive Landscape:
- Boston Scientific Corporation
- Conmed Corporation
- Avanos Medical, Inc.
- Covidien (a Medtronic plc company)
- Fresenius Kabi AG
- Halyard Health, Inc. (now part of Avanos)
- Vygon SA
- Applied Medical Technology, Inc. (AMT)
More Trending Latest Reports By Polaris Market Research:
Organic Food And Beverages Market
Veterinary Endotracheal Tubes Market
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek